Last reviewed · How we verify

Ulcerative Colitis — Treatment Landscape & Competitive Intelligence

Ulcerative Colitis (Gastroenterology) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

Gastroenterology 10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Ulcerative Colitis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Zeposia OZANIMOD Bristol-Myers Squibb Sphingosine 1-phosphate Receptor Modulator Sphingosine 1-phosphate receptor 1 2020-01-01
Jyseleca FILGOTINIB Gilead Sciences Ireland UC Tyrosine-protein kinase JAK1 2020-01-01
Xeljanz tofacitinib Pfizer JAK inhibitor Janus kinase (JAK) enzymes 2012-01-01
Xeljanz Tofacitinib Citrate Pfizer JAK inhibitor Janus kinase (JAK) enzymes 2012-01-01
Simponi GOLIMUMAB Centocor Ortho Biotech Inc Tumor Necrosis Factor Blocker [EPC] Tumor necrosis factor 2009-01-01
Humira ADALIMUMAB AbbVie TNF blocker Tumor Necrosis Factor-alpha (TNF-alpha) 2002-01-01
Abrilada Adalimumab-Afzb AbbVie TNF blocker Tumor necrosis factor-alpha (TNF-alpha) 2002-01-01
Colazal BALSALAZIDE Valeant Pharms Intl Aminosalicylate Prostaglandin G/H synthase 1 2000-01-01
Ovidrel CHORIOGONADOTROPIN ALFA Merck KGaA Gonadotropin Lutropin-choriogonadotropic hormone receptor 2000-01-01
Remicade Infliximab-Dyyb Johnson & Johnson TNF blocker Tumor Necrosis Factor alpha (TNFα) 1998-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. Pfizer · 9 drugs in Ulcerative Colitis
  2. Johnson & Johnson · 4 drugs in Ulcerative Colitis
  3. AbbVie · 2 drugs in Ulcerative Colitis
  4. · 2 drugs in Ulcerative Colitis
  5. Meda Pharms · 2 drugs in Ulcerative Colitis
  6. Centocor Ortho Biotech Inc · 1 drug in Ulcerative Colitis
  7. Gilead Sciences Ireland UC · 1 drug in Ulcerative Colitis
  8. Bristol-Myers Squibb · 1 drug in Ulcerative Colitis
  9. Generic (originally Schering) · 1 drug in Ulcerative Colitis
  10. Generic (originally Merck/Upjohn) · 1 drug in Ulcerative Colitis
  11. Biocon Biologics UK Ltd · 1 drug in Ulcerative Colitis
  12. Eli Lilly · 1 drug in Ulcerative Colitis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Ulcerative Colitis:

Cite this brief

Drug Landscape (2026). Ulcerative Colitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/ulcerative-colitis. Accessed 2026-05-13.

Related